Evidence map›Paper›PMID 40201245›Full record

ArticleHeliyon2025

Retraction notice to "Progress of nanopreparation technology applied to volatile oil drug delivery systems" [Heliyon 10 (2024) e24302].

Zu-Wen Ye, Qi-Yue Yang, Qiao-Hong Lin, Xiao-Xia Liu, Feng-Qin Li, Hong-Da Xuan, Ying-Yan Bai, Ya-Peng Huang, Le Wang, Fang Wang

Abstract readRetraction Notice
In one paragraph

Article in Heliyon, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Zu-Wen YeCancer Research Centre, Jiangxi University of Chinese Medicine, 330004, China.
Qi-Yue YangAffiliated Hospital of Chengdu University of Chinese Medicine, 610072, China.
Qiao-Hong LinCancer Research Centre, Jiangxi University of Chinese Medicine, 330004, China.
Xiao-Xia LiuCancer Research Centre, Jiangxi University of Chinese Medicine, 330004, China.
Feng-Qin LiCancer Research Centre, Jiangxi University of Chinese Medicine, 330004, China.
Hong-Da XuanCancer Research Centre, Jiangxi University of Chinese Medicine, 330004, China.
Ying-Yan BaiCancer Research Centre, Jiangxi University of Chinese Medicine, 330004, China.
Ya-Peng HuangCancer Research Centre, Jiangxi University of Chinese Medicine, 330004, China.
Le WangCancer Research Centre, Jiangxi University of Chinese Medicine, 330004, China.
Fang WangCancer Research Centre, Jiangxi University of Chinese Medicine, 330004, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This retracts the article DOI: 10.1016/j.heliyon.2024.e24302.].

Identifiers

PMID40201245
PMCPMC11949174

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.